Troy E. Messick,Garry R. Smith,Allen B. Reitz,Paul M. Lieberman,Mark E. McDonnell,Yan Zhang,Marianne Carlsen,Shuai Chen
申请号：
US15571223
公开号：
US20180305312A1
申请日:
2016.05.14
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides EBNA1 inhibitors, and/or pharmaceutical compositions comprising the same, that are useful for the treatment of diseases caused by EBNA1 activity, such as, but not limited to, cancer, infectious mononucleosis, chronic fatigue syndrome, multiple sclerosis, systemic lupus erythematosus and/or rheumatoid arthritis. The present invention further provides EBNA1 inhibitors, and/or pharmaceutical compositions comprising the same, that are useful for the treatment of diseases caused by latent Epstein-Barr Virus (EBV) infection and/or lytic EBV infection.
